(Q36307536)
Statements
Effects of exenatide on measures of diabetic neuropathy in subjects with type 2 diabetes: results from an 18-month proof-of-concept open-label randomized study (English)
Brian Callaghan
Catherine L Martin
Morton B Brown
James W Albers
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference